CLINICAL_TRIALS
trial_result
· 2019-05-23
Clinical Trial Update: Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes [Phase 2]
Summary
Phase 2 trial update evaluating the efficacy of oral vismodegib across basal cell carcinoma subtypes completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Basal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2019-05-23